Comparison
Briefed vs Bloomberg.
Compare the tools by how they are used.
Briefed Research and the Bloomberg Terminal serve overlapping but distinct needs. This page sets out what each does so you can make the right call. If Bloomberg is the right tool for your work, buy Bloomberg. If you need evidence-backed company research without a Terminal licence, that is where Briefed fits.
What each tool does.
| Need | Briefed Research | Bloomberg Terminal |
|---|---|---|
| Evidence-backed company researchBriefed cites primary filings inline. Bloomberg aggregates analyst coverage and raw data. | ✓ | ✓ |
| AI-assisted analyst workflowsBriefed Research uses Anya for continuous monitoring with evidence attached. Bloomberg offers Bloomberg Intelligence and BQNT for quantitative work. | ✓ | ✓ |
| Continuous company monitoringBoth track the companies you follow. The delivery mechanism differs: Briefed surfaces a grounded summary; Bloomberg surfaces the raw feed. | ✓ | ✓ |
| Live order book and market dataBloomberg's real-time price and depth data is the core of the Terminal. Briefed carries no live market data. | No | ✓ |
| Execution and portfolio managementBEMS, AIM, and PORT are execution and attribution tools built into the Terminal. Briefed has no execution layer. | No | ✓ |
| IB messaging (Bloomberg Chat)Bloomberg MSG is the institutional communication standard. Briefed has no messaging product. | No | ✓ |
| Fixed income, derivatives, FX dataBloomberg covers instruments and data sets Briefed does not attempt. | No | ✓ |
| Individual self-serve accessBriefed Research starts at £1,990 a year, paid individually. Bloomberg Terminal licences are sold by the seat to institutions, typically £20,000+ per year. | ✓ | No |
| UK public markets and ownership dataBriefed Intelligence tracks UK PSC and company ownership as a structured layer. Bloomberg carries this but as raw filings rather than a resolved ownership graph. | ✓ | ✓ |
| No Bloomberg subscription requiredBriefed Research gives analysts and portfolio managers a grounded research workflow without a Terminal licence. | ✓ | No |
The right tool depends on your situation.
You already have Bloomberg and want better AI-assisted research
Briefed Research and Bloomberg are not either/or if you're a Terminal subscriber. Briefed surfaces a grounded, source-cited layer on top of the companies you follow. Some research teams run both.
You can't justify Bloomberg and need research capability
Briefed Research is the alternative most worth evaluating. It does not replace execution, market data, or IB messaging, but if your core need is understanding what is happening at the companies you track, it covers that ground at a fraction of the cost.
You are a buy-side institution evaluating both
Talk to the Enterprise team. The data infrastructure layer and the research platform are sold separately and can be integrated alongside existing Terminal licences rather than replacing them.
What each costs.
Briefed Research is priced for individual access, billed annually, with no minimum commitment. Bloomberg Terminal licences run around £25k per seat per year, priced by negotiation, and are typically bought by institutions rather than individuals.
Enterprise and institutions
Talk to the teamFor licences that sit alongside an existing Bloomberg setup.